Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Oertel

Showing results (121-130 of 130) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 130 results.
Journal of Hepatology|March 4, 2014
A switch in the source of ATP production and a loss in capacity to perform glycolysis are hallmarks of hepatocyte failure in advance liver diseaseTaichiro Nishikawa, Nadège Bellance, Aaron Damm, et al.
Hepatology (Baltimore, Md.)|October 13, 2017
Dual catenin loss in murine liver causes tight junctional deregulation and progressive intrahepatic cholestasisTirthadipa Pradhan-Sundd, Lili Zhou, Ravi Vats, et al.
Advances in Radiation Oncology|March 10, 2023
Radiation Therapy in the German Hodgkin Study Group HD 16 and HD 17 Trials: Quality Assurance and Dosimetric Analysis for Hodgkin Lymphoma in the Modern EraMichael Oertel, Dominik Hering, Nina Nacke, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 3, 2025
Tumor volume change at radiation boost planning to estimate the response to chemoradiotherapy in stage III unresectable NSCLC (TORCH): a multicenter retrospective observational studySimon Trommer, Jörg Andreas Müller, Michael Oertel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 9, 2025
Comparison of survival and progression after focal- or whole brain radiotherapy in patients with primary CNS lymphoma - Results from a large multicenter analysis of the German Society of Radiation Oncology's Neuro-Radio-Oncology Working Group (DEGRO AG-NRO)Sina Heider, Luisa Allwohn, Alexander Rühle, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 23, 2022
Dose-escalated re-irradiation improves outcome in locally recurrent head and neck cancer - Results of a large multicenter analysisJohannes Roesch, Michael Oertel, Simone Wegen, et al.
Journal of Cancer Research and Clinical Oncology|December 23, 2025
Impact of comorbidities on treatment management and prognosis in patients with anaplastic thyroid cancer (ATC)Teresa Augustin, Dmytro Oliinyk, Marlen Haderlein, et al.
Cell Metabolism|February 5, 2019
Inhibiting Glutamine-Dependent mTORC1 Activation Ameliorates Liver Cancers Driven by β-Catenin MutationsAdeola O Adebayo Michael, Sungjin Ko, Junyan Tao, et al.
Blood|March 13, 2026
Radiotherapy for indolent primary cutaneous B-cell lymphoma: an international multicenter ILROG analysisMichael Oertel, Bouthaina S Dabaja, Dennis Görlich, et al.
Nature|March 13, 2025
Hepatic stellate cells control liver zonation, size and functions via R-spondin 3Atsushi Sugimoto, Yoshinobu Saito, Guanxiong Wang, et al.
Pageof 13

Showing results (121-130 of 130) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 130 results.
Journal of Hepatology|March 4, 2014
A switch in the source of ATP production and a loss in capacity to perform glycolysis are hallmarks of hepatocyte failure in advance liver diseaseTaichiro Nishikawa, Nadège Bellance, Aaron Damm, et al.
Hepatology (Baltimore, Md.)|October 13, 2017
Dual catenin loss in murine liver causes tight junctional deregulation and progressive intrahepatic cholestasisTirthadipa Pradhan-Sundd, Lili Zhou, Ravi Vats, et al.
Advances in Radiation Oncology|March 10, 2023
Radiation Therapy in the German Hodgkin Study Group HD 16 and HD 17 Trials: Quality Assurance and Dosimetric Analysis for Hodgkin Lymphoma in the Modern EraMichael Oertel, Dominik Hering, Nina Nacke, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 3, 2025
Tumor volume change at radiation boost planning to estimate the response to chemoradiotherapy in stage III unresectable NSCLC (TORCH): a multicenter retrospective observational studySimon Trommer, Jörg Andreas Müller, Michael Oertel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 9, 2025
Comparison of survival and progression after focal- or whole brain radiotherapy in patients with primary CNS lymphoma - Results from a large multicenter analysis of the German Society of Radiation Oncology's Neuro-Radio-Oncology Working Group (DEGRO AG-NRO)Sina Heider, Luisa Allwohn, Alexander Rühle, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 23, 2022
Dose-escalated re-irradiation improves outcome in locally recurrent head and neck cancer - Results of a large multicenter analysisJohannes Roesch, Michael Oertel, Simone Wegen, et al.
Journal of Cancer Research and Clinical Oncology|December 23, 2025
Impact of comorbidities on treatment management and prognosis in patients with anaplastic thyroid cancer (ATC)Teresa Augustin, Dmytro Oliinyk, Marlen Haderlein, et al.
Cell Metabolism|February 5, 2019
Inhibiting Glutamine-Dependent mTORC1 Activation Ameliorates Liver Cancers Driven by β-Catenin MutationsAdeola O Adebayo Michael, Sungjin Ko, Junyan Tao, et al.
Blood|March 13, 2026
Radiotherapy for indolent primary cutaneous B-cell lymphoma: an international multicenter ILROG analysisMichael Oertel, Bouthaina S Dabaja, Dennis Görlich, et al.
Nature|March 13, 2025
Hepatic stellate cells control liver zonation, size and functions via R-spondin 3Atsushi Sugimoto, Yoshinobu Saito, Guanxiong Wang, et al.
Pageof 13